Microfluidic co-cultures with hydrogel-based ligand trap to study paracrine signals giving rise to cancer drug resistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microfluidic co-cultures with hydrogel-based ligand trap to study paracrine signals giving rise to cancer drug resistance
Authors
Keywords
-
Journal
LAB ON A CHIP
Volume 15, Issue 24, Pages 4614-4624
Publisher
Royal Society of Chemistry (RSC)
Online
2015-11-03
DOI
10.1039/c5lc00948k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using reconfigurable microfluidics to study the role of HGF in autocrine and paracrine signaling of hepatocytes
- (2015) Dipali Patel et al. Integrative Biology
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations
- (2015) Tamás Garay et al. PATHOLOGY & ONCOLOGY RESEARCH
- Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes
- (2015) E Nummenmaa et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Photodegradable Hydrogels for Capture, Detection, and Release of Live Cells
- (2014) Dong-Sik Shin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The role of MEK inhibitors in the treatment of metastatic melanoma
- (2014) Antonio M. Grimaldi et al. CURRENT OPINION IN ONCOLOGY
- Reconfigurable microfluidics with integrated aptasensors for monitoring intercellular communication
- (2014) Timothy Kwa et al. LAB ON A CHIP
- Efficient production and purification of extracellular domain of human FGFR-Fc fusion proteins from Chinese hamster ovary cells
- (2014) Aleksandra Sokolowska-Wedzina et al. PROTEIN EXPRESSION AND PURIFICATION
- Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies
- (2013) S Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
- (2013) Fang Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
- (2013) K E Ware et al. Oncogenesis
- Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
- (2012) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Mechanisms of acquired resistance to targeted cancer therapies
- (2012) Mark R Lackner et al. Future Oncology
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology
- (2011) Yandong Gao et al. BIOMEDICAL MICRODEVICES
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
- (2010) H. Yang et al. CANCER RESEARCH
- Co-culture of neurons and glia in a novel microfluidic platform
- (2010) Devi Majumdar et al. JOURNAL OF NEUROSCIENCE METHODS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas
- (2010) John T. Lee et al. Pigment Cell & Melanoma Research
- Micropatterned co-cultures of T-lymphocytes and epithelial cells as a model of mucosal immune system
- (2009) Gulnaz Stybayeva et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Directing hepatic differentiation of embryonic stem cells with protein microarray-based co-cultures
- (2009) Ji Youn Lee et al. Integrative Biology
- Cellular observations enabled by microculture: paracrine signaling and population demographics
- (2009) Maribella Domenech et al. Integrative Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More